002370 亚太药业
已收盘 07-03 15:00:00
资讯
新帖
简况
亚太药业(002370)披露与专业投资机构共同投资进展公告,7月2日股价上涨0.17%
证券之星 · 07-02
亚太药业(002370)披露与专业投资机构共同投资进展公告,7月2日股价上涨0.17%
异动快报:亚太药业(002370)6月29日10点16分触及涨停板
证券之星 · 06-29
异动快报:亚太药业(002370)6月29日10点16分触及涨停板
亚太药业(002370)披露全资子公司拟设立香港子公司,6月26日股价下跌5.61%
证券之星 · 06-26
亚太药业(002370)披露全资子公司拟设立香港子公司,6月26日股价下跌5.61%
异动快报:亚太药业(002370)6月23日9点43分触及涨停板
证券之星 · 06-23
异动快报:亚太药业(002370)6月23日9点43分触及涨停板
亚太药业(002370)披露子公司完成工商登记公告,6月17日股价下跌0.58%
证券之星 · 06-17
亚太药业(002370)披露子公司完成工商登记公告,6月17日股价下跌0.58%
亚太药业(002370.SZ)子公司拟3000万元认购投资基金份额
智通财经 · 06-16
亚太药业(002370.SZ)子公司拟3000万元认购投资基金份额
亚太药业(002370.SZ)拟设立子公司 重点探索光动力创新类药物及配套医疗器械的开发
智通财经 · 06-11
亚太药业(002370.SZ)拟设立子公司 重点探索光动力创新类药物及配套医疗器械的开发
亚太药业(002370)披露全资子公司参与认购产业基金暨关联交易公告,6月1日股价下跌0.33%
证券之星 · 06-01
亚太药业(002370)披露全资子公司参与认购产业基金暨关联交易公告,6月1日股价下跌0.33%
股市必读:亚太药业年报 - 第四季度单季净利润同比下降102.35%
证券之星 · 04-27
股市必读:亚太药业年报 - 第四季度单季净利润同比下降102.35%
亚太药业最新公告:一季度净亏损258.75万元
证券之星 · 04-24
亚太药业最新公告:一季度净亏损258.75万元
亚太药业(002370)披露关于变更签字注册会计师的公告,4月15日股价上涨4.3%
证券之星 · 04-15
亚太药业(002370)披露关于变更签字注册会计师的公告,4月15日股价上涨4.3%
亚太药业:公司不参加上述会议
证券之星 · 04-14
亚太药业:公司不参加上述会议
沪指V型反弹,福建本地股爆发,平潭发展4天2板,铝概念掀涨停潮
21世纪经济报道 · 03-30
沪指V型反弹,福建本地股爆发,平潭发展4天2板,铝概念掀涨停潮
亚太药业(002370)披露关于增加2026年度日常关联交易预计额度的议案,3月25日股价上涨2.44%
证券之星 · 03-25
亚太药业(002370)披露关于增加2026年度日常关联交易预计额度的议案,3月25日股价上涨2.44%
股市必读:亚太药业(002370)3月23日收盘跌5.52%,主力净流出1881.91万元
证券之星 · 03-24
股市必读:亚太药业(002370)3月23日收盘跌5.52%,主力净流出1881.91万元
亚太药业(002370)披露对外投资设立子公司公告,3月4日股价上涨0.31%
证券之星 · 03-04
亚太药业(002370)披露对外投资设立子公司公告,3月4日股价上涨0.31%
亚太药业(002370.SZ)子公司拟参设亚钛星浩 完善业务链条
智通财经 · 03-04
亚太药业(002370.SZ)子公司拟参设亚钛星浩 完善业务链条
亚太药业在浙江成立控股新公司
财闻 · 03-03
亚太药业在浙江成立控股新公司
亚太药业(002370)披露全资子公司完成工商登记公告,3月2日股价下跌3.78%
证券之星 · 03-02
亚太药业(002370)披露全资子公司完成工商登记公告,3月2日股价下跌3.78%
亚太药业:公司预计2025年度营业收入3.5亿元-3.7亿元
证券之星 · 02-05
亚太药业:公司预计2025年度营业收入3.5亿元-3.7亿元
暂无数据
公司概况
公司名称:
浙江亚太药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-03-16
主营业务:
浙江亚太药业股份有限公司的主营业务是化学制剂的研发、生产和销售。公司的主要产品是阿莫西林克拉维酸钾分散片、阿奇霉素分散片、注射用阿奇霉素、罗红霉素胶囊、头孢克肟胶囊、注射用头孢唑肟钠、注射用头孢美唑钠、注射用泮托拉唑钠、注射用奥美拉唑钠、奥美拉唑肠溶胶囊、兰索拉唑肠溶胶囊、注射用利巴韦林、注射用阿昔洛韦、注射用更昔洛韦、心血管药、解热镇痛药。
发行价格:
16.00
{"stockData":{"symbol":"002370","market":"SZ","secType":"STK","nameCN":"亚太药业","latestPrice":5.72,"timestamp":1783062234000,"preClose":5.8,"halted":0,"volume":38254197,"delay":0,"changeRate":-0.0138,"floatShares":746000000,"shares":746000000,"eps":0.1362,"marketStatus":"已收盘","change":-0.08,"latestTime":"07-03 15:00:00","open":5.8,"high":5.92,"low":5.6,"amount":219000000,"amplitude":0.0552,"askPrice":5.73,"askSize":1722,"bidPrice":5.72,"bidSize":394,"shortable":0,"etf":0,"ttmEps":0.1362,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.8,"symbolType":"stock","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":6.38,"lowLimit":5.22,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":745667530,"isCdr":false,"pbRate":3.87,"roa":"--","peRate":41.997063,"roe":"--","epsLYR":0.13,"committee":-0.206844,"marketValue":4265000000,"turnoverRate":0.0513,"status":1,"floatMarketCap":4265000000},"requestUrl":"/m/hq/s/002370/tweets","defaultTab":"tweets","newsList":[{"id":"2648518686","title":"亚太药业(002370)披露与专业投资机构共同投资进展公告,7月2日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648518686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648518686?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:40","pubTimestamp":1783003226,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘,亚太药业报收于5.8元,较前一交易日上涨0.17%,最新总市值为43.25亿元。该股当日开盘5.83元,最高6.07元,最低5.71元,成交额达3.25亿元,换手率为7.42%。近日,亚太药业披露《关于与专业投资机构共同投资的进展公告》。嘉兴雨燕已完成工商登记,执行事务合伙人为北京积木私募基金管理有限公司,出资额1亿元,经营范围为股权投资。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002370","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647427243","title":"异动快报:亚太药业(002370)6月29日10点16分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647427243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647427243?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699655,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息,10点16分亚太药业(002370)触及涨停板。其所属行业化学制药目前上涨。领涨股为广生堂。该股为幽门螺杆菌概念,化学原料药,医药概念热股,当日幽门螺杆菌概念概念上涨3.3%,化学原料药概念上涨2.6%,医药概念上涨2.57%。6月26日的资金流向数据方面,主力资金净流出337.19万元,占总成交额2.05%,游资资金净流出53.99万元,占总成交额0.33%,散户资金净流入391.18万元,占总成交额2.38%。近5日资金流向一览见下表:亚太药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900008177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365086","title":"亚太药业(002370)披露全资子公司拟设立香港子公司,6月26日股价下跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646365086?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:48","pubTimestamp":1782485303,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,亚太药业报收于4.88元,较前一交易日下跌5.61%,最新总市值为36.39亿元。近日,亚太药业披露《关于全资子公司对外投资设立香港子公司的公告》。公告显示,公司全资子公司浙江雅泰利众控股有限公司拟以自有资金180万美元在中国香港设立子公司亚太药业国际有限公司,注册资本180万美元,持股比例100%。该事项已于2026年6月26日经公司第八届董事会第十五次会议审议通过,无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600046009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645400168","title":"异动快报:亚太药业(002370)6月23日9点43分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2645400168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645400168?lang=zh_cn&edition=full","pubTime":"2026-06-23 09:46","pubTimestamp":1782179201,"startTime":"0","endTime":"0","summary":"证券之星6月23日盘中消息,9点43分亚太药业(002370)触及涨停板。其所属行业化学制药目前上涨。领涨股为新华制药。该股为化学原料药,医药,幽门螺杆菌概念概念热股,当日化学原料药概念上涨3.09%,医药概念上涨2.96%,幽门螺杆菌概念概念上涨1.87%。6月22日的资金流向数据方面,主力资金净流出1435.34万元,占总成交额11.94%,游资资金净流出195.22万元,占总成交额1.62%,散户资金净流入1630.56万元,占总成交额13.56%。近5日资金流向一览见下表:亚太药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300009877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644712701","title":"亚太药业(002370)披露子公司完成工商登记公告,6月17日股价下跌0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644712701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644712701?lang=zh_cn&edition=full","pubTime":"2026-06-17 17:36","pubTimestamp":1781688992,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘,亚太药业报收于5.12元,较前一交易日下跌0.58%,最新总市值为38.18亿元。该股当日开盘5.15元,最高5.17元,最低5.07元,成交额达6025.76万元,换手率为1.58%。近日,浙江亚太药业股份有限公司发布公告称,其全资子公司浙江雅泰利众控股有限公司以自有资金2,000.00万元设立子公司浙江盛曜光研药业有限公司。该子公司已完成工商登记,并取得绍兴市越城区市场监督管理局颁发的营业执照。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700030668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643512437","title":"亚太药业(002370.SZ)子公司拟3000万元认购投资基金份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2643512437","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643512437?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:25","pubTimestamp":1781609156,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚太药业(002370.SZ)发布公告,公司全资子公司浙江雅泰利众控股有限公司作为有限合伙人,拟以自有资金出资3000万元认购嘉兴雨燕股权投资合伙企业(有限合伙)的基金扩募份额,占其认缴出资总额的30%。该基金将投资于医药研发、生产、服务及创新技术等大健康产业领域优质的未上市公司股权、已上市公司的非公开交易证券等股权类资产。此次投资旨在借助专业投资机构的产业资源、基金运作及专业投资管理经验,进一步拓展医药健康领域的投资布局,与行业优质企业加深合作关系,储备优质研发项目,进一步推动公司产业的长远布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455106.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002370","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642402985","title":"亚太药业(002370.SZ)拟设立子公司 重点探索光动力创新类药物及配套医疗器械的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2642402985","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642402985?lang=zh_cn&edition=full","pubTime":"2026-06-11 15:50","pubTimestamp":1781164230,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚太药业 发布公告,根据发展战略和经营规划需要,为进一步完善公司产业发展布局,全资子公司雅泰利众拟以自有资金2000万元设立子公司浙江盛曜光研药业有限公司(暂定名)。光动力是一种利用光敏剂、特定波长光源与氧分子反应破坏病变组织的医疗技术,广泛应用于肿瘤治疗、皮肤病及部分炎症性疾病,是当下医药健康行业的前沿赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002370","BK1583","159883","09996","BK0239","BK1574","BK1100","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640095865","title":"亚太药业(002370)披露全资子公司参与认购产业基金暨关联交易公告,6月1日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640095865","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640095865?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:00","pubTimestamp":1780308042,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,亚太药业报收于5.96元,较前一交易日下跌0.33%,最新总市值为44.44亿元。该股当日开盘5.9元,最高6.2元,最低5.89元,成交额达1.33亿元,换手率为2.95%。公司于近日披露《关于全资子公司参与认购产业基金暨关联交易的公告》。本次投资构成关联交易,已获董事会审议通过,不构成重大资产重组,无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100028329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630133518","title":"股市必读:亚太药业年报 - 第四季度单季净利润同比下降102.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630133518","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630133518?lang=zh_cn&edition=full","pubTime":"2026-04-27 02:02","pubTimestamp":1777226538,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,亚太药业报收于6.96元,上涨1.75%,换手率4.66%,成交量34.74万手,成交额2.4亿元。股本股东变化股东户数变动近日亚太药业披露,截至2026年3月31日公司股东户数为8.81万户,较12月31日增加9495.0户,增幅为12.08%。董事会关于独立董事2025年度独立性自查情况的专项意见浙江亚太药业股份有限公司董事会根据相关法规要求,对公司2025年度在任独立董事吕海洲、刘岳辉、蔡敏的独立性情况进行评估。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700004857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629825550","title":"亚太药业最新公告:一季度净亏损258.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629825550","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629825550?lang=zh_cn&edition=full","pubTime":"2026-04-24 23:40","pubTimestamp":1777045212,"startTime":"0","endTime":"0","summary":"亚太药业(002370.SZ)公告称,2026年第一季度实现营业收入5957.63万元,同比下降7.71%;归属于上市公司股东的净利润亏损258.75万元。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400067789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627076644","title":"亚太药业(002370)披露关于变更签字注册会计师的公告,4月15日股价上涨4.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627076644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627076644?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:05","pubTimestamp":1776243954,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘,亚太药业报收于7.52元,较前一交易日上涨4.3%,最新总市值为56.07亿元。该股当日开盘7.33元,最高7.53元,最低7.08元,成交额达7.99亿元,换手率为14.55%。漏玉燕自2014年9月成为注册会计师,近三年签署上市公司审计报告超过2家次,曾于2025年4月因武汉天喻信息产业股份有限公司2023年年报审计项目部分审计程序不到位被湖北证监局出具警示函。本次变更不会对公司2025年度审计工作产生不利影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002370","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627955467","title":"亚太药业:公司不参加上述会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2627955467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627955467?lang=zh_cn&edition=full","pubTime":"2026-04-14 08:46","pubTimestamp":1776127569,"startTime":"0","endTime":"0","summary":"证券之星消息,亚太药业(002370)04月13日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,董秘,请问一下就是贵公司是否会参加今年的AACR会议的召开?亚太药业回复:您好,感谢您对公司的关注!公司不参加上述会议。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400006242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002370","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623398628","title":"沪指V型反弹,福建本地股爆发,平潭发展4天2板,铝概念掀涨停潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2623398628","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623398628?lang=zh_cn&edition=full","pubTime":"2026-03-30 11:49","pubTimestamp":1774842540,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 记者|黎雨桐 见习记者林芊蔚。 3月30日,A股早盘探底回升,沪指拉升翻红,此前一度跌超1%,创业板指、深成指跌幅明显收窄。 福建本地股异动拉升,平潭发展4天2板,海峡创新涨超10%,厦门港务、路桥信息、漳州发展、福建金森、东百集团、福建水泥跟涨。航天军工股集体拉升,广联航空涨超10%,航天南湖涨超6%。投资者据此操作,风险自担。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-30/doc-inhsttra9801068.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-30/doc-inhsttra9801068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002160","BK0140","BK0028","512510","BK0188","000905.SH","600547","515890","BK0106","000688.SH","01787","BK0054","BK0096","BK0070","512880","BK4535","BK0230","159967","399001","000592","002370","399006","BK0012","510300","BK0077","000300.SH","510880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622721440","title":"亚太药业(002370)披露关于增加2026年度日常关联交易预计额度的议案,3月25日股价上涨2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622721440","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622721440?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:31","pubTimestamp":1774449070,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘,亚太药业报收于6.29元,较前一交易日上涨2.44%,最新总市值为46.9亿元。该股当日开盘6.13元,最高6.31元,最低6.13元,成交额达9676.35万元,换手率为2.07%。近日,浙江亚太药业股份有限公司发布《关于召开2026年第二次临时股东会的通知》。股权登记日为2026年4月7日。会议将审议《关于增加2026年度日常关联交易预计额度的议案》。会议登记时间为2026年4月8日,可通过现场、信函、电子邮件或传真方式登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500044364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621083070","title":"股市必读:亚太药业(002370)3月23日收盘跌5.52%,主力净流出1881.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621083070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621083070?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:44","pubTimestamp":1774287857,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,亚太药业报收于5.82元,下跌5.52%,换手率3.09%,成交量23.07万手,成交额1.37亿元。当日关注点来自交易信息汇总:亚太药业股价连续3日下跌,3月23日收盘报5.82元,跌5.52%。前10个交易日资金流向情况:主力资金累计净流出9409.17万元,股价累计下跌12.49%;融资余额累计减少767.58万元,融券余量累计增加0股。资金流向3月23日主力资金净流出1881.91万元;游资资金净流出150.96万元;散户资金净流入2032.87万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616556209","title":"亚太药业(002370)披露对外投资设立子公司公告,3月4日股价上涨0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616556209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616556209?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:26","pubTimestamp":1772634379,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘,亚太药业报收于6.49元,较前一交易日上涨0.31%,最新总市值为48.39亿元。该股当日开盘6.45元,最高6.57元,最低6.39元,成交额达8861.47万元,换手率为1.83%。近日,亚太药业披露《关于对外投资设立子公司的公告》。公告显示,公司全资子公司浙江雅泰利众控股有限公司与海南泰泽丰医药科技有限公司于2026年3月4日签订《投资合作协议》,拟共同出资设立浙江亚钛星浩药业有限公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400040285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002370","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616535336","title":"亚太药业(002370.SZ)子公司拟参设亚钛星浩 完善业务链条","url":"https://stock-news.laohu8.com/highlight/detail?id=2616535336","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616535336?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:29","pubTimestamp":1772616565,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚太药业(002370.SZ)公告,公司全资子公司雅泰利众于2026年3月4日与泰泽丰医药签订《投资合作协议》,双方拟共同出资设立浙江亚钛星浩药业有限公司(暂定名,简称“亚钛星浩”),亚钛星浩注册资本1000万元,其中雅泰利众出资600万元,占注册资本的60%,泰泽丰医药出资400万元,占注册资本的40%。据悉,实施该事项有利于进一步完善公司在医药领域的业务链条,提升产业协同效应与综合竞争实力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616239070","title":"亚太药业在浙江成立控股新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2616239070","media":"财闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616239070?lang=zh_cn&edition=full","pubTime":"2026-03-03 13:25","pubTimestamp":1772515500,"startTime":"0","endTime":"0","summary":"企查查APP显示,近日,浙江雅泰利众控股有限公司成立,注册资本5000万元,经营范围包含:控股公司服务;以自有资金从事投资活动;自有资金投资的资产管理服务等。企查查股权穿透显示,该公 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260303/c675039714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0132","BK0239","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616355817","title":"亚太药业(002370)披露全资子公司完成工商登记公告,3月2日股价下跌3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616355817","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616355817?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:30","pubTimestamp":1772461842,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,亚太药业报收于6.62元,较前一交易日下跌3.78%,最新总市值为49.36亿元。近日,浙江亚太药业股份有限公司发布公告称,公司拟以自有资金5,000.00万元设立全资子公司浙江雅泰利众投资控股有限公司。该子公司已完成工商登记手续,并取得绍兴市越城区市场监督管理局颁发的营业执照。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200039864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609701003","title":"亚太药业:公司预计2025年度营业收入3.5亿元-3.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609701003","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609701003?lang=zh_cn&edition=full","pubTime":"2026-02-05 20:51","pubTimestamp":1770295895,"startTime":"0","endTime":"0","summary":"证券之星消息,亚太药业02月04日在投资者关系平台上答复投资者关心的问题。根据《深圳证券交易所股票上市规则》相关规定,最近一个会计年度经审计的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值,且扣除后的营业收入低于3亿元,深交所对其股票交易实施退市风险警示。根据公司于2026年1月31日披露的《2025年度业绩预告》,公司预计2025年度营业收入3.5亿元-3.7亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500037632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783269809217,"stockEarnings":[{"period":"1week","weight":0.1721},{"period":"1month","weight":-0.0035},{"period":"3month","weight":-0.2676},{"period":"6month","weight":-0.2175},{"period":"1year","weight":0.4444},{"period":"ytd","weight":-0.2175}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0421},{"period":"6month","weight":0.0188},{"period":"1year","weight":0.1683},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江亚太药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"88101人(较上一季度增加12.08%)","perCapita":"8463股","listingDate":"2010-03-16","address":"浙江省绍兴市柯桥区群贤路2003号1501室","registeredCapital":"74566万元","survey":" 浙江亚太药业股份有限公司的主营业务是化学制剂的研发、生产和销售。公司的主要产品是阿莫西林克拉维酸钾分散片、阿奇霉素分散片、注射用阿奇霉素、罗红霉素胶囊、头孢克肟胶囊、注射用头孢唑肟钠、注射用头孢美唑钠、注射用泮托拉唑钠、注射用奥美拉唑钠、奥美拉唑肠溶胶囊、兰索拉唑肠溶胶囊、注射用利巴韦林、注射用阿昔洛韦、注射用更昔洛韦、心血管药、解热镇痛药。","listedPrice":16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚太药业(002370)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚太药业(002370)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚太药业,002370,亚太药业股票,亚太药业股票老虎,亚太药业股票老虎国际,亚太药业行情,亚太药业股票行情,亚太药业股价,亚太药业股市,亚太药业股票价格,亚太药业股票交易,亚太药业股票购买,亚太药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚太药业(002370)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚太药业(002370)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}